IMS: 2010 U.S. prescription drug spending per capita real growth of only 0.6%
Recently, IMS Global Medical Health Information Science (IMS) announced in 2010, the U.S. per capita real consumption of prescription drugs rose 0.6%, significantly lower than the annual growth rate of 3.1% in 2009 (see Figure 1). IMS Research Institute in its latest report - "2010 Annual Review of U.S. drug use" that U.S. prescription drug sales in 2010 reached 3,074 billion U.S. dollars; per capita pharmaceutical spending $ 898, compared with 2009 growth of $ 6; 2010, U.S. prescription drug sales the amount of overall growth at historical low levels.
GDP deflator based on 2010 actual total pharmaceutical spending from 261 billion in 2006 to grow to 277 billion U.S. dollars.
According to population estimates, the actual consumption in 2010 from $ 867 per capita in 2006 increased to $ 898 per capita.
Over the past 5 years, the actual annual per capita health care expenditures in the introduction of prescription drug insurance plans the highest growth of 4.9% in 2006 to negative growth in 2008 varied between 1.3% volatility.